Chong Kun Dang Pharmaceutical
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 27 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Chong Kun Dang Pharmaceutical as a sponsor: 27 trials, 27 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Recruiting | Not yet recruiting | Completed | Unknown status | All statuses |
|---|---|---|---|---|---|
| Phase 2 | 0 | 0 | 1 | 1 | 2 |
| Phase 3 | 1 | 0 | 11 | 5 | 17 |
| Phase 4 | 0 | 1 | 4 | 3 | 8 |
| All phases | 1 | 1 | 16 | 9 | 27 |
Start year
| Start year | Trials |
|---|---|
| 2026 | 1 |
| 2024 | 1 |
| 2023 | 3 |
| 2022 | 2 |
| 2019 | 2 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 4 |
| 2014 | 3 |
| 2013 | 1 |
| 2012 | 3 |
| 2011 | 2 |
| 2010 | 2 |
Main conditions
Main countries
- South Korea
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Chong Kun Dang Pharmaceutical
- Sponsor class
- INDUSTRY
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 27
Record details
- Record id
cardio:org-chong-kun-dang-pharmaceutical- Content hash
14fd678b265d78f1e19d3c4db6bcfd27e3505a1474fa1979fc1c19ed49c2918c